In the era of targeted therapy and immunotherapy: advances in the treatment of large B-cell lymphoma of immune-privileged sites

In the era of targeted therapy and immunotherapy: advances in the treatment of large B-cell lymphoma of immune-privileged sites

Primary large B-cell lymphomas of immune-privileged sites (IP-LBCLs) include primary central nervous system large B-cell lymphoma (PCNSL), primary vitreoretinal large B-cell lymphoma (PVRL), and primary testicular large B-cell lymphoma (PTL). These tumors not only have a unique anatomical distributi...

Full description

Saved in:
Bibliographic Details
Main Authors: Haotian Wang, Ying Zhang, Xin Wan, Zhaoxia Li, Ou Bai
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
primary large B-cell lymphomas of immune-privileged sites
targeted therapy
immunotherapy
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1547377/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items